N/A N=9 Randomized Single-blind Other

TMS Alteration of the Reward Positivity

Anhedonia

Bottom Line

View on ClinicalTrials.gov: NCT05443256 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2024

Primary outcome: Primary: Reward Positivity — 2.21; .29 femtoteslas

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Transcranial Magnetic Stimulation (Device)
Age: Adult · 18+ yrs
Sex: All
Sponsor: University of New Mexico
Primary completion: Nov 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Reward Positivity	2.21; .29	—

Summary

The aim of this proposal is to demonstrate that stimulation of different brain regions differently affects the electroencephalographic feature known as the Reward Positivity (RewP).

Eligibility Criteria

Inclusion Criteria

Men or women aged 18-30

Exclusion Criteria

Participants unwilling or unable to give informed consent
Presence of other known medical or psychiatric comorbidity that in the investigator's opinion would compromise participation in the study
MEG/MRI contraindications
History of psychosis
Not fluent in English

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05443256). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.